Recombinant Meleagris gallopavo Growth/differentiation factor 8 (MSTN)

Shipped with Ice Packs
In Stock

Description

Molecular Characterization of Turkey MSTN

The MSTN gene in Meleagris gallopavo spans ~8.0 kb with three exons and two introns, encoding a 330-amino acid precursor protein . Post-translational processing yields a 12 kDa mature glycoprotein (109 amino acids) that inhibits myoblast proliferation and differentiation . Key structural features include:

DomainCharacteristics
PropeptideBinds mature MSTN to form latent complexes, regulating bioavailability
Mature peptideHomodimerizes to bind activin type II receptors (e.g., ACTRIIB), inhibiting muscle growth

Phylogenetic analysis places turkey MSTN within the piscine mstn1 clade, distinct from mammalian and avian orthologs . The gene shares 93–100% exon sequence similarity with chicken, duck, and quail MSTN .

Genetic Polymorphisms and Functional Implications

A 2022 study on Black Bronze turkeys identified 32 SNPs in the MSTN coding region, with six non-synonymous mutations altering four amino acids in exon 1 and two in exon 2 :

ExonSNP PositionAmino Acid ChangeBody Weight Association
145 A>GK15RLinked to higher body weight (6,700 g)
150 A>GQ17RObserved in high-growth phenotypes
2339 A>CK90TAssociated with low body weight

Comparative Genomics and Adaptive Evolution

Taq I PCR-RFLP analysis revealed species-specific restriction sites in turkey MSTN (e.g., 1471 bp fragment in exon 1), distinguishing it from chicken orthologs . Evolutionary analyses suggest:

  • Positive selection in the MSTN propeptide region among sub-Saharan African human populations .

  • Conserved inhibitory function across vertebrates, with poultry-specific adaptations in regulatory regions .

Challenges and Future Directions

  1. Knowledge Gaps: No published protocols exist for recombinant Meleagris gallopavo MSTN production.

  2. Agricultural Potential: CRISPR/Cas9 editing of MSTN could enhance meat yields, but ethical and welfare considerations remain .

  3. Therapeutic Prospects: MSTN propeptide analogs show promise for treating muscle atrophy, warranting turkey-specific trials .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C is recommended. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize developing it.
Synonyms
MSTN; GDF8Growth/differentiation factor 8; GDF-8; Myostatin
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
267-375
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Meleagris gallopavo (Wild turkey)
Target Names
Target Protein Sequence
DFGL DCDEHSTESR CCRYPLTVDF EAFGWDWIIA PKRYKANYCS GECEFVFLQK YPHTHLVHQA NPRGSAGPCC TPTKMSPINM LYFNGKEQII YGKIPAMVVD RCGCS
Uniprot No.

Target Background

Function
Acts as a negative regulator of skeletal muscle growth.
Database Links
Protein Families
TGF-beta family
Subcellular Location
Secreted.

Q&A

Experimental Design for Studying Recombinant MSTN Function

Question: What methodologies are optimal for validating recombinant MSTN activity in vitro and in vivo?

Answer:
Recombinant MSTN validation requires multi-layered approaches to assess biological activity and tissue specificity:

In Vitro Validation

  • Transfection and Secretion Analysis

    • Use mammalian expression vectors (e.g., pcDNA 3.1 Zeo) to overexpress MSTN in myoblasts (e.g., C2C12 cells) .

    • Confirm secretion via Western blotting of conditioned medium using COOH-terminal-specific antibodies (e.g., Santa Cruz C-20) .

  • Functional Assays

    • Measure inhibition of myogenic differentiation markers (e.g., MyoD, myogenin) via RT-PCR or immunoblotting .

    • Reversal experiments: Neutralize recombinant MSTN with COOH-terminal antibodies to restore differentiation (Fig. 3C in ).

In Vivo Validation

  • Genetic Models

    • Compare muscle phenotypes between wild-type and MSTN-overexpressing turkeys using qPCR to quantify mRNA levels in liver, breast, and thigh tissues .

    • Track age-dependent expression patterns (e.g., higher MSTN in grower vs. finisher stages) .

  • Phenotypic Correlation

    • Link MSTN expression to carcass traits (e.g., body weight, muscle mass) using linear regression or GWAS .

Tissue-Specific Expression and Age-Related Dynamics

Question: How does MSTN expression vary across tissues and developmental stages in turkeys?

Answer:
MSTN expression is context-dependent, with significant tissue and age effects:

Tissue6-Week Expression16-Week ExpressionKey Observations
BreastHigh ΔCT (12.82, R=1.38) in local black turkeys Reduced expression in exotic turkeys (ΔCT=10.60, R=1.24) Higher expression in grower phase correlates with slower muscle differentiation
LiverStrong MSTN activity in local breeds Sustained expression in exotic turkeys Suggests systemic regulation of myogenesis
ThighModerate expressionDecline in both local and exotic turkeys Age-dependent downregulation aligns with muscle maturation

Methodological Note: Real-time PCR with 2^(-ΔΔCT) quantification is critical for comparing expression across breeds (local vs. exotic) and tissues .

Genetic Variations and Phenotypic Outcomes

Question: How do SNPs in MSTN influence muscle growth and carcass traits in turkeys?

Answer:
Single nucleotide polymorphisms (SNPs) in MSTN are linked to divergent phenotypes, as demonstrated in Black Bronze turkeys:

Key Findings

  • SNP Identification

    • Target MSTN exons for sequencing to identify coding SNPs (e.g., using Sanger sequencing or NGS) .

    • Prioritize SNPs in functional domains (e.g., propeptide region, mature peptide) .

  • Phenotypic Correlation

    • SNPs in MSTN are associated with:

      • Body weight: Higher MSTN expression in breast tissue correlates with reduced growth .

      • Carcass traits: SNPs in IGF-2 (synergistic with MSTN) impact muscle mass .

  • Evolutionary Context

    • Sub-Saharan African populations exhibit higher MSTN variant frequencies (up to 31%), suggesting adaptive divergence .

Data Table: MSTN SNPs and Phenotypic Associations

SNP LocationAlleleTrait AssociationSource
Exon 2 (propeptide)A/GHigher body weight in GG genotype
Intron 1C/TIncreased carcass yield in CC genotype

Addressing Data Contradictions in MSTN Studies

Question: How can researchers reconcile conflicting findings on MSTN expression levels across turkey breeds?

Answer:
Conflict resolution requires rigorous experimental design and statistical analysis:

  • Source of Variation

    • Genetic background: Heritage vs. exotic breeds exhibit distinct haplotypes (e.g., mtDNA SNPs in D-loop/16S rRNA regions) .

    • Age and tissue sampling: Standardize protocols for grower (6 weeks) vs. finisher (16 weeks) stages .

  • Methodological Controls

    • Normalization: Use housekeeping genes (e.g., β-actin) for qPCR to account for RNA quality .

    • Replication: Include biological replicates (n=50 turkeys in ) to mitigate technical noise.

  • Meta-Analysis

    • Integrate data from mitochondrial DNA studies , MSTN SNPs , and expression profiles to identify conserved regulatory elements.

Advanced Research Frontiers

Question: What novel approaches can elucidate MSTN’s role in turkey myogenesis?

Answer:
Cutting-edge techniques include:

  • CRISPR-Cas9 Editing

    • Generate MSTN knockout turkeys to study muscle hypertrophy and validate recombinant protein efficacy.

  • Proteomic Profiling

    • Map MSTN interactome (e.g., ACTRIIB receptors, SMAD proteins) using co-IP/mass spectrometry .

  • Epigenetic Regulation

    • Investigate DNA methylation patterns in MSTN promoters to explain breed-specific expression differences .

  • Cross-Species Comparative Genomics

    • Contrast MSTN’s evolutionary trajectory in turkeys with cattle (double-muscled breeds) and humans .

Challenges in Recombinant MSTN Production

Question: What technical hurdles limit recombinant MSTN production for functional studies?

Answer:
Key challenges include:

  • Protein Processing

    • Proper cleavage of propeptide and mature peptide domains is critical for bioactivity .

    • Validate using Western blotting for monomeric (12 kDa) and dimeric forms .

  • Tissue-Specific Delivery

    • Systemic vs. localized administration affects muscle targeting efficiency.

    • Use viral vectors (e.g., AAV) for in vivo studies to enhance delivery.

  • Ethical and Practical Constraints

    • Limited availability of turkey-specific antibodies necessitates cross-reactivity testing (e.g., anti-mouse MSTN antibodies) .

Integrating Multi-Omics Data

Question: How can researchers combine transcriptomic, proteomic, and phenotypic data to model MSTN’s regulatory network?

Answer:
A systems biology approach is essential:

  • Data Integration

    • Overlay MSTN expression (qPCR) with carcass traits (body weight, breast yield) using WGCNA or PPI networks .

  • Haplotype Analysis

    • Link MSTN SNPs to mitochondrial haplotypes (e.g., D-loop variants) to identify co-evolved loci .

  • Evolutionary Context

    • Contrast human MSTN adaptation with turkey domestication to infer selective pressures .

Critical Analysis of Commercial vs. Academic Research

Question: How do academic studies differ from industry-driven MSTN research in turkeys?

Answer:
Academic research focuses on mechanistic insights, while industry prioritizes applied outcomes:

AspectAcademic FocusIndustrial Focus
ObjectiveElucidate MSTN’s role in myogenesisOptimize breeding for meat yield
MethodCRISPR knockouts, transfectionMarker-assisted selection
OutputPeer-reviewed publicationsPatented breeding programs

Note: Academic studies often provide foundational data for industrial applications (e.g., SNP validation in ).

Future Directions

Question: What unresolved questions remain in MSTN research for turkey biology?

Answer:

  • Species-Specific Mechanisms

    • Determine whether turkey MSTN shares structural/functional homology with human MSTN’s propeptide processing .

  • Environmental Interactions

    • Study how aflatoxin exposure (via GST-mediated detoxification ) modulates MSTN expression.

  • Epigenetic Regulation

    • Map MSTN promoter methylation patterns across breeds to explain expression divergence .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.